Navigation Links
ESCEO-IOF Servier Pierre D. Delmas Prize awarded to John. A. Kanis
Date:3/23/2011

Today, at the opening of the European Congress on Osteoporosis & Osteoarthritis in Valencia, Spain, Professor John A. Kanis was awarded the 2nd ESCEO-IOF Servier Pierre D. Delmas Prize.

The prestigious award, granted by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) with the support of Servier, honours an individual who has made outstanding and major scientific contributions to the study of bone and mineral diseases. Consisting of a grant of 40,000 and an honorary medal, the award is named after the late Pierre Delmas, Professor of Medicine and Rheumatology at the University of Lyon, France, and Director of the INSERM research unit 'Pathophysiology of Osteoporosis'. Professor Delmas was an outstanding scientist who directed essential basic and clinical research in metabolic bone diseases. He was one of the leading proponents of osteoporosis advocacy worldwide in his role as IOF President.

Prof. John A. Kanis is currently the Emeritus Professor in Human Metabolism and Clinical Biochemistry and the Director of the WHO Collaborating Centre for Metabolic Bone Diseases, University in Sheffield, UK. Prof. Kanis' research interests are largely related to disorders of skeletal metabolism including osteoporosis, Paget's disease of bone, hyperparathyroidism, renal osteodystrophy and neoplasia affecting the skeleton. He has also made a number of national and international contributions to guideline development, health technology assessment, epidemiology and health economics. Prof. Kanis is President of the International Osteoporosis Foundation and WHO Advisor on Osteoporosis, among other honorary positions. He is Co Editor-in-Chief of Osteoporosis International, serves on the editorial board of several journals and is the author of more than 800 papers, chapters and books on bone disease and metabolism. His current major interest is in the development of risk assessment algorithms and the formulation of practice guidelines in many regions of the world. Professor Kanis has received numerous honours and awards, most recently the Hamdan Award for Medical Research Excellence in 2010.

The Pierre Delmas Prize is awarded annually by a prize Committee composed of leading scientists chosen within the IOF Committee of Scientific Advisors and ESCEO Scientific Advisory Board. The next Pierre Delmas Prize will be awarded in March 2012 at the European Congress on Osteoporosis and Osteoarthritis (IOF-ECCEO12) to take place in Bordeaux, France.


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. Inaugural Herbert A. Fleisch ESCEO-IOF Medal is awarded to Professor Gerard Karsenty
2. ESCEO-IOF-ABBH Young Investigator Awards recognize research excellence
3. Sam Safran wins EPJE -- Pierre-Gilles De Gennes Lecture Prize
4. Winner of Pierre Delmas Prize announced at World Congress on Osteoporosis 2010
5. UW-Madison lake scientist gets worlds top water prize
6. Heinz Maier-Leibnitz Prizes 2011: Recognition and incentive for early career researchers
7. Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize
8. An Israel prize in his genes
9. Winners to share $1 million prize in Office of Naval Research challenge
10. Filmmakers Joel and Ethan Coen among 2011 Dan David Prize winners
11. Vilcek Foundation names recipients of 2011 Vilcek Prizes in Biomedical Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... 2016 --> ... "Automated Fingerprint Identification System Market by Component (Hardware and ... & Finance, Government, Healthcare, and Transportation) and Geography - ... is expected to be worth USD 8.49 Billion by ... and 2020. The transformation and technology evolution from the ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... Potentials of that Rising Market Are you ... new analysis forecasts revenues for checkpoint inhibitors. Visiongain,s ... world market, submarket, product and national level. ... Instead discover what progress, opportunities and revenues those ...
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first ... (AHA) announced plans to develop a first of its ... power of IBM Watson. In the first application of ... IBM (NYSE: IBM ), and Welltok will create ... health assessments with cognitive analytics, delivered on Welltok,s health ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/5/2016)... , Feb. 5, 2016 Australian-US drug discovery and ... today the appointment of a new Chairman, Mr John ... , effective immediately. James Garner , has ... Director and former Acting CEO, Mr Iain Ross , ... Director. --> James Garner , has also been ...
(Date:2/4/2016)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the leader ... Lanphier , Sangamo,s president and chief executive officer, will ... Therapeutic ® development programs and an overview of ... Thursday, February 11, 2016, at the Leerink Partners 5 ... being held in New York . ...
(Date:2/4/2016)... China , Feb. 4, 2016 Beike ... and various medical institutions attended a ceremony in late ... integrative, personalized cell therapy in 2016. ... "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" was ... Regional Cell Production Center, both subsidiaries of Beike Biotechnology ...
Breaking Biology Technology: